Australian Clinical Labs Share Price and Company Fundamentals
Last traded: Today at 6:10 AM
Australian Clinical Labs Limited provides pathology services. The company offers all routine pathology tests, advanced pathology, first trimester screening and non-invasive prenatal testing, chemical pathologand, haematology, histopathology, immunology, serology and microbiology, functional pathology, and commercial drug and alcohol testing services. It also offers COVID-19, testing guide, GP services, and specialists services. The company offers its service to private and public hospitals. Australian Clinical Labs Limited was incorporated in 1987 and is based in Clayton, Australia. Clinical Laboratories Pty Ltd operates as a subsidiary of Healthscope Group.
|Primary activities||Provision of pathology services|
|Industry / Sector||Diagnostics & Research / Healthcare|
|Full time employees||2716|
|Mailing address||1868-1892 Dandenong Road Clayton VIC 3168 Australia|
|Phone / Fax||61 3 9538 6777 / 61 3 9538 6751|
|Share registry||LINK MARKET SERVICES LIMITED|
Australian Clinical Labs does not pay dividends.
As of Jul 2021, following are the company executives and directors listed on Australian Clinical Labs.
|Ms. Melinda McGrath||CEO & Exec. Director|
|Mr. James Davison||Chief Financial Officer|
|Mr. Anthony Friedli||Chief Operating Officer|
|Mr. Sean Jackson||Chief Information Officer|
|Mr. Joe Geran||National Marketing Director|
|Associate Prof. Tony Landgren||National Medical Director & Chief Pathologist|
|Mr. Chris Brownlow||Chief Exec. Officer of New South Wales & Australian Capital Territory|
|Ms. Shae Seymour||Chief Exec. Officer of Western Australia|
|Mr. Eric Swayn||Chief Exec. Officer of South Australia & Northern Territory|
Profitability and management effectiveness
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Australian Clinical Labs is 758.9M and its enterprise value is 756.6M. The enterprise value to revenue ratio of ACL is 1.46.
Companies similar to Australian Clinical Labs (ACL)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Australian Clinical Labs (ASX:ACL) Frequently Asked Questions
1. What is Australian Clinical Labs's Stock Symbol?
Australian Clinical Labs trades on ASX under the ticker symbol "ACL".
2. What is Australian Clinical Labs's stock price today?
One share of ACL stock can currently be purchased for approximately $3.76.
3. How can I contact Australian Clinical Labs?
Australian Clinical Labs's mailing address is 1868-1892 Dandenong Road Clayton VIC 3168 Australia. The company can be reached via phone at 61 3 9538 6777.
4. What is Australian Clinical Labs's official website?
The official website of Australian Clinical Labs is http://www.clinicallabs.com.au.
5. Which share registry manages Australian Clinical Labs's stock?
Australian Clinical Labs's stock is managed by LINK MARKET SERVICES LIMITED.